Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022GlobeNewsWire • 11/29/22
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare ConferenceGlobeNewsWire • 11/02/22
Does Avid Bioservices (CDMO) Have the Potential to Rally 61% as Wall Street Analysts Expect?Zacks Investment Research • 10/17/22
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceGlobeNewsWire • 09/07/22
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent DevelopmentsGlobeNewsWire • 09/06/22
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell BusinessGlobeNewsWire • 09/01/22
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022GlobeNewsWire • 08/30/22
Avid Bioservices, Inc. (CDMO) CEO Nick Green on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/30/22
Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent DevelopmentsGlobeNewsWire • 06/29/22
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022GlobeNewsWire • 06/22/22
Avid Bioservices, Inc. and CRB highlight efforts that enabled opening of first phase of new viral vector facility in California in only eight monthsPRNewsWire • 06/16/22
Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing FacilityGlobeNewsWire • 06/14/22
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell BusinessGlobeNewsWire • 06/13/22
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech ForumGlobeNewsWire • 03/16/22
Avid Bioservices' (CDMO) CEO Nick Green on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 03/09/22
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022GlobeNewsWire • 03/01/22
Avid Bioservices (CDMO) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 02/17/22
Avid Bioservices (CDMO) Gains But Lags Market: What You Should KnowZacks Investment Research • 02/02/22
Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North FacilityGlobeNewsWire • 01/10/22